HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shih-Ping Chen Selected Research

Neoplasms (Cancer)

10/2016Retraction to "Ellipticine-induced apoptosis depends on Akt translocation and signaling in lung epithelial cancer cells".
11/2015Erratum to: The collective nuclear migration of p53 and phosphorylated S473 of Akt during ellipticine-mediated apoptosis in human lung epithelial cancer cells.
9/2015The collective nuclear migration of p53 and phosphorylated S473 of Akt during ellipticine-mediated apoptosis in human lung epithelial cancer cells.
1/2009Ellipticine-induced apoptosis depends on Akt translocation and signaling in lung epithelial cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shih-Ping Chen Research Topics

Disease

4Neoplasms (Cancer)
10/2016 - 01/2009
3Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)
01/2019 - 01/2013
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2015 - 01/2009
1Papillary Thyroid Cancer
03/2016
1Stroke (Strokes)
03/2016
1Viremia
10/2013
1Porcine Reproductive and Respiratory Syndrome (PRRS)
10/2013
1Disease Susceptibility (Diathesis)
01/2013

Drug/Important Bio-Agent (IBA)

4ellipticineIBA
10/2016 - 01/2009
1Long Noncoding RNAIBA
01/2019
1P-2 (P 2)IBA
03/2016
1Topoisomerase II InhibitorsIBA
09/2015
1Topoisomerase InhibitorsIBA
09/2015
1Biomarkers (Surrogate Marker)IBA
02/2015
1Peptides (Polypeptides)IBA
10/2013
1VaccinesIBA
10/2013
1EpitopesIBA
10/2013
1Neutralizing AntibodiesIBA
10/2013
1ExotoxinsIBA
10/2013
1LigandsIBA
10/2013
1Complement System Proteins (Complement)IBA
10/2013
1AntigensIBA
10/2013
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2013

Therapy/Procedure

1Therapeutics
09/2015